BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27777360)

  • 1. Trends in Antihypertensive Medication Use Among US Patients With Resistant Hypertension, 2008 to 2014.
    Hwang AY; Dave C; Smith SM
    Hypertension; 2016 Dec; 68(6):1349-1354. PubMed ID: 27777360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
    Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
    Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
    de la Sierra A; Armario P; Oliveras A; Banegas JR; Gorostidi M; Vinyoles E; de la Cruz JJ; Segura J; Ruilope LM
    J Hypertens; 2018 Jul; 36(7):1563-1570. PubMed ID: 29601411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Parra D; Rosenstein R
    N Engl J Med; 2009 Mar; 360(11):1147-8; author reply 1149-50. PubMed ID: 19279348
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination antihypertensive therapy among patients with COPD.
    Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
    Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant hypertension: a review of diagnosis and management.
    Vongpatanasin W
    JAMA; 2014 Jun; 311(21):2216-24. PubMed ID: 24893089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.
    Psaty BM; Savage PJ; Tell GS; Polak JF; Hirsch CH; Gardin JM; McDonald RH
    JAMA; 1993 Oct; 270(15):1837-41. PubMed ID: 8105112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in chronic kidney disease-treatment standard 2023.
    Georgianos PI; Agarwal R
    Nephrol Dial Transplant; 2023 Nov; 38(12):2694-2703. PubMed ID: 37355779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.
    Calhoun DA
    J Clin Hypertens (Greenwich); 2007 Jan; 9(1 Suppl 1):19-24. PubMed ID: 17215651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.
    Yamanari H; Nakamura K; Miura D; Yamanari S; Ohe T
    Clin Exp Hypertens; 2009 Oct; 31(7):585-94. PubMed ID: 19886856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.